Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Medetomidine, which is used to sedate pets and is somewhat similar to xylazine, was first detected in illegally manufactured ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...

Eli Lilly is set to report Q1 earnings on May 1. Analysts predict strong growth, but margin pressures and guidance revisions ...

US benchmark equity indexes closed higher on Tuesday despite soft labor data and weak consumer sentiment. The Nasdaq increased 0.6% to 14,461.32, while the S&P 500 gained 0.6% to 5,560.83. The Dow ...

The strategy comes as rival Eli Lilly & Co. is working with telehealth firms to distribute lower-cost vials of its own ...

The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...

Following the Q1 print, Raymond James analyst Jayson Bedford lowered his price target for Intuitive Surgical stock to $592 from $688, but reiterated a Buy rating. The 5-star analyst noted that the ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.